Related Experiment Video

Updated: Jun 12, 2026

Pediatric Animal Model of Extracorporeal Cardiopulmonary Resuscitation After Prolonged Circulatory Arrest
04:55

Pediatric Animal Model of Extracorporeal Cardiopulmonary Resuscitation After Prolonged Circulatory Arrest

Published on: May 26, 2023

Pediatric Emergency Research Networks: a global initiative in pediatric emergency medicine

Terry P Klassen1, Jason Acworth, Liza Bialy

  • 1Department of Pediatrics, University of Alberta, Edmonton, Canada.

European Journal of Emergency Medicine : Official Journal of the European Society for Emergency Medicine
|June 5, 2010
PubMed

Insights

Pediatric Emergency Research Network (PERN) aims to improve child health globally through collaborative research. Initial efforts focus on H1N1 risk factors, with future plans for broader international studies.

Area of Science:

  • Pediatric Emergency Medicine
  • Global Health Research Networks
  • Child Health Outcomes

Background:

  • The Pediatric Emergency Research Network (PERN) convened to foster collaboration among international pediatric emergency medicine research networks.
  • Discussions focused on sharing network missions, research contributions, and best practices to enhance effectiveness.

Framework:

  • The meeting established a common goal for high-quality research and knowledge dissemination to improve care for acutely ill and injured children worldwide.
  • PERN aims to promote quality of care for children and youth globally through collaborative research initiatives.

Implementation:

  • Delegates from five major pediatric emergency medicine research networks (USA, Canada, Australia/New Zealand, Europe/Middle East) attended the 2009 meeting.
  • PERN is developing a protocol to assess H1N1 risk factors using retrospective data collection.

Implications:

  • The inaugural meeting revealed a shared commitment to advancing pediatric emergency medicine research.
  • Future plans include presenting H1N1 research findings and organizing a 2010 meeting to discuss further global collaborations.
Abstract

More Related Videos

Neonatal Pial Surface Electroporation06:22

Neonatal Pial Surface Electroporation

Published on: May 7, 2014

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Cardiopulmonary Resuscitation III: AED Use01:23

Cardiopulmonary Resuscitation III: AED Use

Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...